VIP 6 MG

Dragon Pharma VIP 6 mg – Synthetic Vasoactive Intestinal Peptide for Research

Dragon Pharma VIP 6 mg is a synthetic form of Vasoactive Intestinal Peptide (VIP), a 28-amino-acid human neuropeptide hormone that functions as a potent vasodilator, neurotransmitter, and immune system regulator. Produced naturally in the gastrointestinal tract, pancreas, and brain, VIP plays critical roles in smooth muscle relaxation, fluid and electrolyte secretion, and the modulation of inflammatory responses.

Each vial contains 6 mg of lyophilized VIP in a 2 mL format, requiring reconstitution with bacteriostatic water before use. This peptide has been extensively studied for its diverse biological activities, including vasodilation, neuroprotection, immunomodulation, and regulation of digestive and respiratory functions. For related research compounds, explore our peptides category and specifically Semax for complementary neuropeptide research applications.

What Makes VIP Valuable in Research?

VIP is a pleiotropic neuropeptide with a wide range of biological effects. Its ability to act as a potent vasodilator, relax smooth muscle, and modulate immune responses makes it a valuable research tool for investigating multiple physiological systems. VIP interacts with specific receptors (VPAC1 and VPAC2) that are widely distributed throughout the body, enabling its diverse functions.

Researchers value VIP for its versatility and its role in connecting nervous, endocrine, and immune systems. Its involvement in conditions ranging from inflammation and autoimmune disorders to gastrointestinal and respiratory function makes it relevant to numerous research areas. For investigators exploring immune-modulating peptides, Thymosin Alpha-1 offers complementary research avenues in immune system regulation.

Current scientific literature on VIP can be accessed through the PubMed database, where researchers can review peer-reviewed studies on its biological activity and experimental applications.

Key Research Applications for Dragon Pharma VIP

• ✔ Investigation of vasodilation and vascular regulation
• ✔ Evaluation of smooth muscle relaxation mechanisms
• ✔ Research on immune system modulation and inflammation
• ✔ Studies of gastrointestinal and respiratory physiology
• ✔ Preclinical models of neuroprotection and neural function

Product Details

Dosage & Usage Guidelines

Reconstitution Protocol

• ✔ Use sterile bacteriostatic water for injection
• ✔ Add appropriate volume to achieve desired concentration
• ✔ Swirl gently to dissolve – do not shake vigorously
• ✔ Store reconstituted solution at 2–8°C

Reconstitute the lyophilized powder using bacteriostatic water to a concentration suitable for your research protocol. The 6 mg format allows for precise dosing across a range of experimental models. Always use aseptic technique during preparation to maintain peptide integrity.

Typical Research Parameters

In research settings, VIP is typically administered via subcutaneous, intravenous, or intraperitoneal injection. Dosing schedules and concentrations vary widely depending on the experimental design, animal model, and specific research objectives.

• ✔ Commonly used in vascular and smooth muscle studies
• ✔ Often combined with physiological and immunological analysis
• ✔ Used to investigate neuropeptide signaling pathways
• ✔ Research models include inflammation, digestion, and respiratory paradigms

Factors to Consider in Research Protocols

• Pleiotropic peptide with multiple receptor targets
• Reconstitution stability is limited; prepare fresh solutions for each use
• Individual variation in response may be observed across subjects
• Storage conditions significantly impact peptide stability

Lab Testing & Batch Transparency

Lab status

COA pending release

Third-party analytical testing (COA) for Dragon Pharma VIP 6 mg is currently not yet available. Batch-specific assay data, purity analysis, and verification documentation will be published once released.

Testing Status

Pending

COA Availability

Not yet published

Batch Verification

In progress

Update

Coming soon

Transparency note: Dragon Pharma publishes batch-specific lab reports once analytical testing is completed and verified.

Awaiting COA

Shipping & Product Authenticity

What to Expect

• ✔ Orders are processed after payment confirmation
• ✔ USA Domestic shipping is typically faster when local stock is selected
• ✔ International orders include tracking, though update frequency may vary by destination
• ✔ Multiple warehouses may result in separate shipments when applicable

For complete delivery details, tracking policy, and reshipment terms, please see our Shipping Info page.

Storage

Store the lyophilized powder at controlled room temperature (15–25°C) in a dry, dark place, away from direct light and moisture. The unopened vial should be kept in its original packaging to maintain stability.

After reconstitution, store the solution at 2–8°C and use within 14 days. Do not freeze. Discard any unused portion after the recommended storage period. Before use, inspect the solution and avoid use if it appears cloudy, discolored, or contains particulate matter, or if the vial or seal is compromised.

Keep out of reach of children. Follow proper handling and sterile injection practices during research use.

Proper storage conditions help maintain product stability and consistent performance across the product's shelf life.

Frequently Asked Questions